Browse > Article
http://dx.doi.org/10.22246/jikm.2017.38.5.828

A Case Report of Diabetes Mellitus with Herniated Intervertebral Lumbar Discs Improved by Korean Medicine Treatment  

Han, Dong-geun (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Choi, A-ryun (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Jung, You-jin (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Kang, Ah-hyun (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Seo, Hye-jin (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Sung, Jae-yeon (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Lee, Hyung-chul (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Eom, Gook-hyun (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Song, Woo-sub (Dept. of Internal Medicine, Gang-nam Ja-Seng Korean Medicine Hospital)
Publication Information
The Journal of Internal Korean Medicine / v.38, no.5, 2017 , pp. 828-833 More about this Journal
Abstract
Objective: The aim of this study was to evaluate the effects of traditional Korean medicine as a treatment for diabetes mellitus with herniated intervertebral lumbar discs. Method: The patients were treated with the herbal medicine Jungso-tang to reduce serum glucose (FBS/PP2hrs) and HbA1c to improve diabetes mellitus in parallel with lumbar herniated intervertebral disc treatment. Results: The treatment with Jungso-tang decreased the serum glucose (FBS/PP2hrs) and HbA1c levels. Conclusion: Korean medicine may be an effective treatment for diabetes mellitus with lumbar herniated intervertebral disc.
Keywords
diabetes mellitus; Korean medicine treatment; case report;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2014;37(Supplement 1):S81-S90.   DOI
2 American Diabetes Association, Standards of medical care in diabetes-2017 Abridged for Primary Care Providers. Clinical Diabetes 2017;35(1):5-26.   DOI
3 Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract 2011;94(3):311-21.   DOI
4 Kim DJ. The Epidemiology of Diabetes in Korea. Diabetes Metab J 2011;35(4):303-8.   DOI
5 BK Tripathi, AK Srivastava. Diabetes mellitus: Complications and therapeutics. Med Sci Monit 2006;12(7):130-47.
6 Ko SH. Clinical Practice Guideline 2015: Oral Hypoglycemic Agents for Patients with Type 2 Diabetes, Korean Diabetes J 2016;17(2):83-7.   DOI
7 Cho SY, Yoo WJ, Ahn SW, KIM NI. The formation of Sogal concept and classification in Korean Traditional Medicine. J Korean Orient Med 2007;13(2):1-14.
8 Kim SW. Reviews : Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus. Korean Diabetes J 2010;34(6):331-7.   DOI
9 Lee SU, Hwang JW, Lee WC. A Case Study of Two Type II Diabetic Patients Diagnosed with Sogal. J Korean Orient Med 2017;38(1):81-91.   DOI
10 Kim DH, Park SC, Lee JH, Lee HY, Cho MK, Choi JY, et al. Recent Research Trends in Korean Medicine Treatment of Diabetes Mellitus - Focusing on Domestic Articles from 2008 to 2013. J Korean Orient Med 2013;34(3):240-55.
11 Son AH, Koh JY, Lee DK, Shin HS. Review of Domestic Experimental Studies of Korean Medicine Treatment for Diabetes Mellitus Since 2013. J Korean Orient Med 2017;38(1):1-11.
12 Korean Diabetes Association. Diabetes Fact Sheet in Korea 2016. Seoul: Korean diabetes association; 2016, p. 2-8.